States / Texas / HB 3057

HB 3057 Enacted

Relating to health benefit plan coverage for chimeric antigen receptor T-cell therapy.

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted

No summary has been published for this bill. The full text is on the Bill text tab.

Chamber
House
Introduced
Feb 19, 2025
Last action
Jun 20, 2025 — Effective on 9/1/25
Session
89R
Momentum
88 · Very high